Skip to main content
. 2016 Sep 5;49(5):1825–1838. doi: 10.3892/ijo.2016.3678

Figure 3.

Figure 3

The effect of erlotinib, lapatinib, sapitinib, afatinib, neratinib, crizotinib, NVP-AEW541 and dasatinib on SKOV3 cell migration determined using the IncuCyte Clear View 96-well IncuCyte Chemotaxis system. Chamber wells were analysed every 3 hours using the IncuCyte chemotaxis software.